{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:09:31Z","timestamp":1768439371763,"version":"3.49.0"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2023.1194241","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T06:11:08Z","timestamp":1684908668000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Editorial: Osteoporosis secondary to endocrine disorders"],"prefix":"10.3389","volume":"14","author":[{"given":"El\u017cbieta","family":"Skowro\u0144ska-J\u00f3\u017awiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2019.1575727","article-title":"Understanding and managing secondary osteoporosis","volume":"14","author":"Colangelo","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1013362","article-title":"The effects of season (spring versus autumn) on diagnosis of normocalcemic primary hyperparathyroidism e","volume":"13","author":"Basi\u0144ska-Lewandowska","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","article-title":"Interpreting global trends in type 2 diabetes complications and mortality","volume":"65","author":"Ali","year":"2022","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413662","article-title":"Obesity and bone: A complex relationship","volume":"22","author":"Rinonapoli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2021.04.008","article-title":"Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease","volume":"32","author":"Lim","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/a-1556-7784","article-title":"Autonomous aldosterone secretion as a subclinical form of primary aldosteronism: Pathogenesis and clinical significance","volume":"130","author":"Kmie\u0107","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.14341\/probl200955215-18","article-title":"Clinical polymorphism of congenital x-linked adrenal hypoplasia","volume":"55","author":"Orlova","year":"2009","journal-title":"Probl Endokrinol (Mosk)."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6614-5-14","article-title":"Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels","volume":"5","author":"Skowro\u0144ska-J\u00f3\u017awiak","year":"2012","journal-title":"Thyroid Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/948384","article-title":"Mechanisms of normalisation of bone metabolism during recovery from hyperthyroidism: Potential role for sclerostin and parathyroid hormone","volume":"2015","author":"Skowro\u0144ska-J\u00f3\u017awiak","year":"2015","journal-title":"Int J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1194241\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T06:11:09Z","timestamp":1684908669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1194241\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":11,"alternative-id":["10.3389\/fendo.2023.1194241"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1194241","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"article-number":"1194241"}}